Concurrent Versus Sequential Intrapleural tPA-DNase Administration: Comparative Effectiveness and Safety in Pleural Infection [0.03%]
同期和序贯胸腔内尿激酶-聚乙二醇重组人粒细胞系集落刺激因子给药：胸腔感染中的有效性和安全性比较研究
Lakshay Jain,Anil Perumbeti
Lakshay Jain
Rationale and objectives: Intrapleural tissue plasminogen activator (tPA) plus deoxyribonuclease (DNase) improves drainage in pleural infection, but the optimal administration sequence is uncertain. We evaluated whether c...
Generalizability of symptom-based subtypes of moderate to severe OSA patients within and between ethnic groups [0.03%]
基于症状的中重度OSA患者亚型在不同族群内的泛化能力
Huijie Yi,Jingjing Guo,Brendan T Keenan et al.
Huijie Yi et al.
Objectives: Multiple studies have shown that symptom-based subtypes of obstructive sleep apnea (OSA) exist and are generalizable to clinical and population-based samples of different race/ethnic and regional backgrounds. ...
Adherence to elexacaftor/tezacaftor/ivacaftor (ETI) among people with cystic fibrosis: the yETI study [0.03%]
艾瑞可泰维 triplet（ETI）在囊性纤维化患者中的用药依从性：yETI 研究
Robin S Everhart,Christine Ford,Sidney L Gibson et al.
Robin S Everhart et al.
Representation of Minoritized People with Cystic Fibrosis in CF Therapeutics Development Network Clinical Trials [0.03%]
囊性纤维化治疗开发网络临床试验中少数族裔囊性纤维化的患者特征
Tijana Milinic,Amalia S Magaret,Crystal E Brown et al.
Tijana Milinic et al.
Rationale: Black and Hispanic people with CF (PwCF) experience worse health outcomes related to pulmonary disease compared to White, non-Hispanic PwCF. Improving outcomes in minoritized PwCF is a crucial need in the CF co...
Impact of two years of treatment with Elexacaftor/Tezacaftor/Ivacaftor on longitudinal changes in structural lung disease in people with Cystic Fibrosis - Results from the RECOVER trial [0.03%]
杜伐柯玛斯特/泰韦凯玛斯特/伊维凯玛斯特治疗两年对囊性纤维化患者肺结构疾病纵向变化的影响：来自RECOVER试验的结果
Paul McNally,Karen Lester,Rachel Cregan et al.
Paul McNally et al.
Rationale: Progressive structural lung disease (SLD) is a key hallmark of cystic fibrosis. The CFTR modulator combination Elexacaftor/Tezacaftor/Ivacaftor (ETI) is associated with short term improvements in SLD measured o...
The Child Opportunity Index and Discharge Disposition among Children with New Tracheostomy and Long-Term Mechanical Ventilation [0.03%]
儿童机会指数与新的气管造口术和长期机械通气儿童的出院结果的关系
Lindsey L Scheller,Abbey Alkon,Thomas J Hoffmann et al.
Lindsey L Scheller et al.
Rationale: Although discharge to home is the goal for many children on new long-term mechanical ventilation via tracheostomy (LTMV-T), families often face barriers to access such as home health nursing. Disparities in dis...
Respiratory Mortality per STAR, GOLD, and ERS/ATS COPD Severity Classification [0.03%]
基于STAR、GOLD和ERS/ATS慢性阻塞性肺疾病严重程度分类的呼吸系统死亡率
Surya P Bhatt,Sandeep Bodduluri,Elizabeth A Regan et al.
Surya P Bhatt et al.
Rates and Characteristics of Bronchiectasis-Related Hospitalizations in the United States in 2022: A Population-Based Cohort Study [0.03%]
2022年美国支气管扩张症相关住院率及特征的基于人群队列研究
Meagan Deviaene,Victoria Haldane,Jason E Black et al.
Meagan Deviaene et al.
Background: Bronchiectasis, a condition defined by radiographic evidence of abnormally widened airways, is increasing in prevalence. Previous studies have demonstrated increased morbidity and health care utilization among...
Long-term exposure to air pollution and risk of adult-onset asthma and COPD: Danish nationwide cohort study [0.03%]
长期接触空气污染与成人期起病哮喘和慢性阻塞性肺疾病风险的关系：丹麦全国队列研究
Rina So,Jiawei Zhang,Marie Bergmann et al.
Rina So et al.
Rationale: Long-term exposure to air pollution contributes to chronic respiratory diseases, including asthma and chronic obstructive pulmonary disease (COPD). While the effect of fine particulate matter (PM2.5) and nitrog...
Building Resilience When Disaster Strikes: Adapting Clinical Trials in Critical Illness Recovery [0.03%]
灾难来临时的恢复能力构建：重症病患康复期临床试验的适应性调整
Anna G Kalema,Felipe González-Seguel,Louisa A Summers et al.
Anna G Kalema et al.